SCHEMBL6865405

SCHEMBL6865405

CC(C)(C)C1(C(C)(C)C)CNc2ccccc21

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM1A O60341 1/20 0.36
PDK2 Q15119 1/20 0.34
PDK4 Q16654 1/20 0.34
ATM Q13315 1/20 0.34
OPRM1 P35372 1/20 0.32
OPRL1 P41146 1/20 0.32
BACE1 P56817 2/20 0.32
HTR5A P47898 4/20 0.32
MEN1 O00255 1/20 0.31
CYP1A2 P05177 1/20 0.31
BCHE P06276 1/20 0.31
POLB P06746 1/20 0.31
CYP3A4 P08684 1/20 0.31
ADORA3 P0DMS8 1/20 0.31
GAA P10253 1/20 0.31
MAPT P10636 1/20 0.31
ALOX15 P16050 1/20 0.31
ALOX12 P18054 1/20 0.31
MAOA P21397 1/20 0.31
CNR1 P21554 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29384370 0.72 PDK2 (0.42) KDM1APDK2PDK4ATMOPRM1
SCHEMBL1031209 0.72 PDK2 (0.42) KDM1APDK2PDK4ATMOPRM1
Hydrochloric Acid SCHEMBL2482151 0.71 PDK2 (0.41) KDM1APDK2PDK4ATMOPRM1
SCHEMBL2349269 0.69 PDK2 (0.39) KDM1APDK2PDK4ATMHTR5A
SCHEMBL28239774 0.69 PDK2 (0.39) KDM1APDK2PDK4ATMOPRM1
SCHEMBL24124146 0.69 PDK2 (0.39) KDM1APDK2PDK4ATMOPRM1
SCHEMBL30200026 0.68 KDM1A (0.39) KDM1APDK2PDK4OPRM1OPRL1
SCHEMBL20815887 0.68 KDM1A (0.39) KDM1APDK2PDK4OPRM1OPRL1
SCHEMBL1012828 0.68 TNKS (0.44) KDM1APDK2PDK4OPRM1OPRL1
SCHEMBL29479467 0.68 TNKS (0.44) KDM1APDK2PDK4OPRM1OPRL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110053925-A1 Hydroxamate-Based Inhibitors of Deacetylases NOVARTIS AG 2011-03-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110053925-A1 Hydroxamate-Based Inhibitors of Deacetylases HDAC1, HDAC11, HDAC3 KDM1A 26/4885PDK2 404/4885PDK4 664/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.